|
1
|
Kuntz CA, Dernell WS, Powers BE, Devitt C,
Straw RC and Withrow SJ: Prognostic factors for surgical treatment
of soft-tissue sarcomas in dogs: 75 cases (1986–1996). J Am Vet Med
Assoc. 211:1147–1151. 1997.PubMed/NCBI
|
|
2
|
Ettinger SN: Principles of treatment for
soft-tissue sarcomas in the dog. Clin Tech Small Anim Pract.
18:118–122. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McChesney SL, Gillette EL, Dewhirst MW and
Withrow SJ: Influence of WR 2721 on radiation response of canine
soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 12:1957–1963.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ogilvie GK, Reynolds HA, Richardson RC,
Withrow SJ, Norris AM, Henderson RA, Klausner JS, Fowler JD and
McCaw D: Phase II evaluation of doxorubicin for treatment of
various canine neoplasms. J Am Vet Med Assoc. 195:1580–1583.
1989.PubMed/NCBI
|
|
5
|
Ogilvie GK, Obradovich JE, Elmslie RE,
Vail DM, Moore AS, Straw RC, Dickinson K, Cooper MF and Withrow SJ:
Efficacy of mitoxantrone against various neoplasms in dogs. J Am
Vet Med Assoc. 198:1618–1621. 1991.PubMed/NCBI
|
|
6
|
Cronin K, Page RL, Spodnick G, Dodge R,
Hardie EN, Price GS, Ruslander D and Thrall DE: Radiation therapy
and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound.
39:51–56. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bregazzi VS, LaRue SM, McNiel E, Macy DW,
Dernell WS, Powers BE and Withrow SJ: Treatment with a combination
of doxorubicin, surgery, and radiation versus surgery and radiation
alone for cats with vaccine-associated sarcomas: 25 cases
(1995–2000). J Am Vet Med Assoc. 218:547–550. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobayashi T, Hauck ML, Dodge R, Page RL,
Price GS, Williams LE, Hardie EM, Mathews KG and Thrall DE:
Preoperative radiotherapy for vaccine associated sarcoma in 92
cats. Vet Radiol Ultrasound. 43:473–479. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen WR, Adams RL, Bartels KE and
Nordquist RE: Chromophore-enhanced in vivo tumor cell destruction
using an 808-nm diode laser. Cancer Lett. 94:125–131. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen WR, Adams RL, Higgins AK, Bartels KE
and Nordquist RE: Photothermal effects on murine mammary tumors
using indocyanine green and an 808-nm diode laser: An in vivo
efficacy study. Cancer Lett. 98:169–173. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hirano T, Kohno E, Gohto Y and Obana A:
Singlet oxygen generation by irradiation of Indocyanine green (ICG)
and its effect to tissues. J Jpn Soc Laser Surg Med. 28:122–128.
2007.
|
|
12
|
Radzi R, Osaki T, Tsuka T, Imagawa T,
Minami S, Nakayama Y and Okamoto Y: Photodynamic hyperthermal
therapy with indocyanine green (ICG) induces apoptosis and cell
cycle arrest in B16F10 murine melanoma cells. J Vet Med Sci.
74:545–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Onoyama M, Azuma K, Tsuka T, Imagawa T,
Osaki T, Minami S, Ogawa N and Okamoto Y: Effects of photodynamic
hyperthermal therapy with indocyanine green on tumor growth in a
colon 26 tumor-bearing mouse model. Oncol Lett. 7:1147–1150.
2014.PubMed/NCBI
|
|
14
|
Ohguri T, Imada H, Narisada H and Korogi
Y: Clinical results of systemic chemotherapy combined with regional
hyperthermia. Thermal Med (Japanese Journal of Hyperthermic
Oncology). 23:49–61. 2007.(In Japanese). View Article : Google Scholar
|
|
15
|
Onoyama M, Tsuka T, Imagawa T, Osaki T,
Minami S, Azuma K, Kawashima K, Ishi H, Ogawa N and Okamoto Y:
Photodynamic hyperthermal chemotherapy with indocyanine green: A
novel cancer therapy for 16 cases of malignant soft tissue sarcoma.
J Vet Sci. 15:117–123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martano M, Morello E, Ughetto M, Iussich
S, Petterino C, Cascio P and Buracco P: Surgery alone versus
surgery and doxorubicin for the treatment of feline injection-site
sarcomas: A report on 69 cases. Vet J. 170:84–90. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Banerji N and Kanjilal S: Somatic
alterations of the p53 tumor suppressor gene in vaccine-associated
feline sarcoma. Am J Vet Res. 67:1766–1772. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Giudice C, Stefanello D, Sala M, Cantatore
M, Russo F, Romussi S, Travetti O, Di Giancamillo M and Grieco V:
Feline injection-site sarcoma: Recurrence, tumour grading and
surgical margin status evaluated using the three-dimensional
histological technique. Vet J. 186:84–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Phelps HA, Kuntz CA, Milner RJ, Powers BE
and Bacon NJ: Radical excision with five-centimeter margins for
treatment of feline injection-site sarcomas: 91 cases (1998–2002).
J Am Vet Med Assoc. 239:97–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poirier VJ, Thamm DH, Kurzman ID, Jeglum
KA, Chun R, Obradovich JE, O'Brien M, Fred RM III, Phillips BS and
Vail DM: Liposome-encapsulated doxorubicin (Doxil) and doxorubicin
in the treatment of vaccine-associated sarcoma in cats. J Vet
Intern Med. 16:726–731. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davidson EB, Gregory CR and Kass PH:
Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg.
26:265–269. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cohen M, Wright JC, Brawner WR, Smith AN,
Henderson R and Behrend EN: Use of surgery and electron beam
irradiation, with or without chemotherapy, for treatment of
vaccine-associated sarcomas in cats: 78 cases (1996–2000). J Am Vet
Med Assoc. 219:1582–1589. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hahn KA, Endicott MM, King GK and
Harris-King FD: Evaluation of radiotherapy alone or in combination
with doxorubicin chemotherapy for the treatment of cats with
incompletely excised soft tissue sarcomas: 71 cases (1989–1999). J
Am Vet Med Assoc. 231:742–745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Romanelli G, Marconato L, Olivero D,
Massari F and Zini E: Analysis of prognostic factors associated
with injection-site sarcomas in cats: 57 cases (2001–2007). J Am
Vet Med Assoc. 232:1193–1199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hershey AE, Sorenmo KU, Hendrick MJ,
Shofer FS and Vail DM: Prognosis for presumed feline
vaccine-associated sarcoma after excision: 61 cases (1986–1996). J
Am Vet Med Assoc. 216:58–61. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eckstein C, Guscetti F, Roos M, Martín de
las Mulas J, KaserHotz B and Rohrer Bley C: A retrospective
analysis of radiation therapy for the treatment of feline
vaccine-associated sarcoma. Vet Comp Oncol. 7:54–68. 2009.
View Article : Google Scholar : PubMed/NCBI
|
